Thailand Dialysis Market Analysis Sample Report 2022 to 2030

This report presents a strategic analysis of the Thailand Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Dialysis Market, offering unmatched value, accuracy and expert insights.

1. Thailand Dialysis Market
Analysis
Sample Report
June 2024

2. This report presents a strategic analysis of the Thailand Dialysis
Market and a forecast for its development in the medium and long
term. It provides a comprehensive overview of the market value,
dynamics, segmentation, main players, growth and demand drivers,
challenges & future outlook, etc. This is one of the most comprehensive
reports about the Thailand Dialysis Market, and offers unmatched
value, accuracy, and expert insights.

3. 3 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive
Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement
Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Currency Conversion 1 Thai Baht = 0.027 USD
Research Approach Secondary Research (90%), Primary Research (10%)
Report Scope

4. 4 A Sample Report on Thailand Dialysis Market Analysis I Confidential
CONTENT PG. NO.
1. Market Overview 06-14
1.1 Dialysis Market Overview
1.2 Dialysis Market Overview: Global
1.3 Economic Overview: Thailand
1.4 Dialysis Market Overview: Thailand
1.5 Healthcare Overview: Thailand
1.6 Budget of Thailand Government for Public Insurance
1.7 Top Developments in Thailand
2. Process of Dialysis 15-17
2.1 Types of Dialysis
2.2 Mechanisms of Dialysis
3. Market Size and Forecasting 18-23
3.1 Thailand Dialysis Market and Forecasts
Table of Content

5. 5 A Sample Report on Thailand Dialysis Market Analysis I Confidential
CONTENT PG. NO.
3.2 Snapshot of Thailand Dialysis Market Segmentation
3.2.1 Market Segmentation: By Type of Dialysis
3.2.2 Market Segmentation: By Location of End User
3.2.3 Market Segmentation: By Indication
4. Market Dynamics 24-29
4.1 Market Growth Drivers
4.2 Market Growth Restraints
5. Competitive Landscape 30-37
5.1 Key Players in Thailand Dialysis Market
6. Regulatory and Reimbursement Landscape in Thailand 38-43
6.1 Regulatory Landscape in Thailand
6.2 Reimbursement Scenario in Thailand
6.3 Reimbursement Process
Table of Content

6. Thailand Dialysis Market Analysis
1. Market Overview

7. ▪Dialysis is the process of removing excess water, solutes, and toxins from the blood in individuals
whose kidneys can no longer perform these functions naturally. This can occur due to various
chronic kidney diseases (CKD) or acute kidney injury.
▪Causes of kidney failure are varied but generally include diabetes, polycystic kidney disease,
acute kidney injuries, high BP, heart disease, glomerulonephritis, and blocked urinary tract.
▪Dialysis becomes necessary when kidney function has deteriorated significantly, typically below
10-15% of normal function.
The key functions of kidney include:
•Filtering Blood: Kidneys remove waste products like urea, creatinine, and toxins produced by the body's
normal metabolism.
•Maintaining Electrolyte Balance: Kidneys regulate the levels of electrolytes (salts) like sodium, potassium,
and bicarbonate, which are essential for various bodily functions.
•Balancing Fluids: Kidneys control the amount of fluids in the body by removing excess fluid through urine
production.
•Hormone Production: Kidneys produce hormones that regulate blood pressure, red blood cell production, and
other important functions.
1.1 Dialysis Market Overview

8. 8 A Sample Report on Thailand Dialysis Market Analysis I Confidential
563
580
599
620
642
665
689
715
739
761
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Population ages 65 and above globally (in Mn) (2012-2021)
1.2 Dialysis Market Overview: Global (1/2)
7
th
Rank
Kidney dysfunction is
ranked as the 7
th

leading risk factor for
deaths worldwide
2 Mn
People receive dialysis
treatment to stay alive every
year
1.7 Mn
Deaths globally per year
due to Chronic Kidney
Disease (CKD)
700 Mn
Number of individuals
currently have CKD

9. 9 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Thailand Market
~$xx Bn Market
Illustrative
1.2 Dialysis Market Overview: Global (2/2)

10. 10 A Sample Report on Thailand Dialysis Market Analysis I Confidential
16%
69%
15%
2015201620172018201920202021202220232024
Population of Thailand, in Mn (2015-2024)
2013201420152016201720182019202020212022
GDP of Thailand, in Mn (2013-2022)
Population Split (2024)
0-14
15-64
65+
49.75
50.25
Male
Female
By Age GroupBy Gender
▪Thailand is an aging country, as it’s median age is 40.2 years
which is higher than global median age
▪Country's population’s global share is 0.89% and it is increasing
at a rate of 0.15%
▪Life expectancy of female is 84.1 years and for male it is 75.8
years
▪Currently 52.0% of population is urban in Thailand
▪Top 3 largest cities in Thailand is Bangkok, Samut Prakan, and
Mueang Nonthaburi
Illustrative
1.3 Economic Overview: Thailand
Sources:

11. 11 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Thailand is an aging country, as it’s median age is 40.2 years which is higher than global
median age
▪Country's population’s global share is 0.89% and it is increasing at a rate of 0.15%
▪Life expectancy of female is 84.1 years and for male it is 75.8 years
▪Currently 52.0% of population is urban in Spain
▪Top 3 largest cities in Thailand is Bangkok, Samut Prakan, and Mueang Nonthaburi
Illustrative
1.4 Dialysis Market Overview: Thailand
>20,000
People with End-Stage
Kidney Disease
(ESKD) need treatment
of dialysis
1.9%
Of the people aware that
they have CKD
17.5%
Overall prevalence of
Chronic Kidney Disease
in Thailand
8.6%
Of the total 17.5%
population with CKD
already in advanced
stages (stages 3-5)
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Population ages 65 and above (% of Total Population) (2013-2022)
Sources:

12. 12 A Sample Report on Thailand Dialysis Market Analysis I Confidential
1.5 Healthcare Overview: Thailand
Public Healthcare
▪Universal Coverage: Thailand's public healthcare sector
forms the backbone of the country's Universal Health
Coverage (UHC) program
▪Ministry of Public Health (MOPH): It is a central
governing body overseeing public health policy, resource
allocation, and overall healthcare system management
▪National Health Security Office (NHSO): This agency
plays a crucial role in administering the UHC program,
including budgeting, reimbursement mechanisms, and
quality control initiatives for public healthcare providers
▪Public Health Service System: It is a network of
hospitals, health promotion centers, and clinics
▪Strengths of the Public sector: include accessibility,
affordability, focus on primary care, and standardized
practices
Private Healthcare
▪Complimentary: Private sector in Thailand's healthcare
system complements the public sector by offering a wider
range of services and catering to those seeking a more
convenient experience
▪Contracting with NHSO: Some private hospitals and
clinics contract with the NHSO to provide specific
healthcare services to UHC beneficiaries. This helps
bridge gaps in specialized care within the public sector
▪Supplemental Insurance: Many Thai citizens choose to
have private health insurance alongside UHC coverage.
This allows them to access a wider range of services
offered by the private sector or to benefit from higher
coverage limits for specific treatments
▪Benefits offered: Various services offered in the private
sector include advanced medical technology, shorter
waiting times, enhanced patient experience, and
increased access to specialized care

13. 13 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending
accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.6 Budget of Thailand Government for Public Insurance

14. 14 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Company Name Type Year Key Pointers
Investment April, 2024
▪Bangkok Dusit Medical Services (BDMS) is a major player in Thailand's
healthcare sector, offering a comprehensive range of medical services
and actively pursuing advancements in technology and patient care.
▪BDMS invested in Cariva (Thailand) Co. Ltd., a medical technology
startup focusing on AI for healthcare. This investment highlights their
focus on incorporating technology into the healthcare delivery system.
Acquisition 2021
▪Bumrungrad Hospital, one of Thailand's leading private hospitals known
for medical tourism, acquired a majority stake in Bangkok Chain Hospital
(BCH)
▪This acquisition aimed to expand Bumrungrad's network and enhance its
service offerings in different segments of the healthcare market.
Latest Deals in Thailand
Illustrative
1.7 Top Developments in Thailand

15. Thailand Dialysis Market Analysis
2. Process of Dialysis

16. 16 A Sample Report on Thailand Dialysis Market Analysis I Confidential
2.1 Types of Dialysis
Hemodialysis Peritoneal Dialysis
Process
•Blood is removed from the body through a
surgically created access point (fistula or graft)
and circulated outside the body through a dialysis
machine. The machine filters the blood using a
dialyzer, removing waste products and excess
fluid. The cleaned blood is then returned to the
body
•A cleansing fluid (dialysate) is instilled into the
abdominal cavity (peritoneum) through a catheter.
Waste products and excess fluid from the blood
diffuse across the peritoneum membrane into the
dialysate. The dialysate is then drained out of the
body
Location
•Performed in a dialysis center or at home using a
special machine
•Performed at home, allowing for greater flexibility
in scheduling
Frequency
•Typically 3-4 hours per session, 3-7 times per
week
•Can be performed continuously or with exchanges
several times a day


Illustrative

17. 17 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Illustrative
2.2 Mechanisms of Dialysis
Diffusion
•Blood flows through a special filter called a dialyzer which is a semi-permeable membrane within the dialyzer machine
•On one side flows the patient’s blood
•On other side flows the cleansing fluid called the dialysate which is formulated with water and electrolytes to maintain
balance
•Due to the concentration difference, these waste products naturally want to move from an area of high concentration
(blood) to an area of low concentration (dialysate). This movement across the semipermeable membrane is diffusion
Ultrafiltration
•While diffusion removes waste products, our bodies also need a way to get rid of excess fluid that accumulates due to
malfunctioning kidneys. Here ultrafiltration’s role comes into play
•The dialysis machine can create a controlled hydrostatic pressure gradient across the dialyzer membrane. This means
applying a higher pressure on the blood side compared to the dialysate side
•This pressure gradient forces excess fluid from the blood to move across the membrane and into the dialysate
•By removing excess fluid, ultrafiltration helps control fluid balance in the body, a crucial function normally handled by
healthy kidneys

18. Thailand Dialysis Market Analysis
3. Market Size and Forecasting

19. 19 A Sample Report on Thailand Dialysis Market Analysis I Confidential
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Thailand Dialysis Market Forecast, 2023-2030
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Thailand Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Thailand Market Size ($Bn) 61 74 84 87 91 95 99 106
Illustrative
3.1 Thailand Dialysis Market Size and Forecasts

20. 20 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪In this section you will get an understanding of the segmentations which will cover the Thailand Dialysis Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Type of Dialysis
Hemodialysis (HD)
Peritoneal Dialysis (PD)
Location of End User
Hospitals and Clinics
Homecare Settings
Independent Dialysis Centers
Indication
Acute Kidney Injury (AKI)
End Stage Kidney Disease
(ESKD)
Multiple Organ Failure
Chronic Kidney Disease
Others (Poisoning, septic
shock)
Illustrative
3.2 Snapshot of Thailand Dialysis Market Segmentation

21. 21 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Thailand Dialysis Market Share, By Type of Dialysis
(2023)
Hemodialysis
Peritoneal
Dialysis
Illustrative
3.2.1 Market Segmentation: By Type of Dialysis

22. 22 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Thailand Dialysis Market Share, By Location of End User
(2023)
Hospitals and
Clinics
Independent
Dialysis
Centers
Homecare
Settings
Illustrative
3.2.2 Market Segmentation: By Location of End User

23. 23 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Thailand Dialysis Market Share, By Indication
(2023)
Others
Acute Kidney
Injury (AKI)
End Stage
Kidney
Disease
(ESKD)
Multiple Organ
Failure
Chronic Kidney
Disease (CKD)
Illustrative
3.2.3 Market Segmentation: By Indication

24. Thailand Dialysis Market Analysis
4. Market Dynamics

25. 25 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Illustrative
4.1.1
High prevalence of
Chronic Kidney
Disease (CKD)
marked by 17.5% of
the population with
CKD
4.1.2
Thailand as one of
the rapidly aging
countries with 10%
of the population
above 60 years
4.1.3
Technological
advancements in
dialysis machines,
membranes, and
dialysate solutions
4.2.1
High costs and
limited
reimbursement may
hinder the growth of
dialysis market
4.2.2
Shortage of skilled
personnel for the
dialysis treatment
stifles the
expansion of market
4. Snapshot Of Market Growth Drivers And Restraints

26. 26 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Illustrative
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
4.1 Market Growth Drivers
4.1.1 The prevalence of Chronic Kidney Disease (CKD) was 17.5 % overall and 22.2% in the northeastern region of the
total population in 2021 in Thailand
2010 2022 2030
Increasing prevalence of CKD in future

27. 27 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
Illustrative
4.1 Market Growth Drivers
4.1.2 Thailand is classified as an aging country as its median age has steading increased over the past and is
currently at 40.2 years
Increasing median age in future

28. 28 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.3 Technological advancements in dialysis with a focus on improving patient experience, convenience, and
potentially reducing costs
Technological advancements in various sectors

29. 29 A Sample Report on Thailand Dialysis Market Analysis I Confidential
4.2.1 The cost of dialysis in Thailand can range
between $490 to $700 per session
▪Please be aware that this sample
report is intended to provide you
with a brief overview of the kind
of information and analysis that
will be presented in the final
report
▪In order to obtain access to all of
the information that you are
seeking, you will need to
purchase the final report
4.2.2 Shortage of trained healthcare professionals
to manage dialysis can restrict the capacity of the
market
▪Please be aware that this sample
report is intended to provide you
with a brief overview of the kind
of information and analysis that
will be presented in the final
report
▪In order to obtain access to all of
the information that you are
seeking, you will need to
purchase the final report
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Growth Restraints

30. Thailand Dialysis Market Analysis
5. Competitive Landscape

31. 31 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Fresenius Medical
Care AG
1
Bumrungrad
International Hospital
6
Baxter International
Inc.
2 Bangkok Hospital7
DaVita Inc.3 Yanhee Hospital8
Asahi Kasei Medical4 Chaophya Hospital9
B. Braun Melsungen
AG
5
Aek Udon
International Hospital
10
Illustrative
Global Player Local Player
5.2 Key Players in Thailand Dialysis Market

32. 32 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Founded In: 1996
HQ: Bad Homburg, Germany
Type: Private
Revenue: $20.89 Mn (Global)
Website: www.fresenius.com
▪Fresenius Medical Care is the world's largest provider of dialysis
products and services, with a presence in over 100 countries,
including Thailand
▪They care for more than 348,000 patients in the global network of
more than 4,000 dialysis clinics
▪Their core business revolves around the “Renal Care
Continuum,” which encompasses various stages of CKD
management, with dialysis as a central component.
Offerings
➢Dialysis Products
➢Dialysis Services
➢Home Dialysis Solutions
➢Research and Development
Recent Activity / Press Coverage
▪May 21 2024: Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal
Association (ERA) Congress 2024
▪February 8 2024: Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S.,
demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies
▪October 26 2023: Fresenius Medical Care Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis
Clinical Dataset
▪April 5 2023: Fresenius Medical Care wins CIO 100 Award for novel tool to predict intradialytic hypotension
▪March 19 2023 Fresenius Medical Care launches “Augmented Reality” for training on Kidney Replacement Therapy device
5.2.1 Fresenius Medical Care (Continued)

33. 33 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Company Name Type Year Key Pointers
Merger March, 2022
▪Fresenius Medical Care participated in a significant three-way merger in
the United States, aiming to create a premier value-based kidney care
provider.
▪The parties involved were Fresenius Health Partners, InterWell Health,
and Cricket Health. The result of this merger is an independent company
operating under the brand name InterWell Health with more
comprehensive and patient-centered care
Acquisition
December,
2019
▪Fresenius Medical Care acquired Ciame Ltda., a local dialysis treatment
provider in Uruguay which has been commercializing the company’s
product portfolio to a large number of patients with chronic kidney disease
for more than 18 years
▪With this acquisition, FME aims to introduce new technologies and
knowledge to the Uruguayan market, expand the local distribution of its
products and thus make the best therapies available to more patients with
kidney disease throughout the region
Latest Deals in Fresenius Medical Care
Illustrative
5.2.1 Fresenius Medical Care (Continued)

34. 34 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.2.1 Fresenius Medical Care (Continued)

35. 35 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Founded In:
HQ:
Type:
Revenue:
Website:
Offerings
Recent Activity / Press Coverage
5.2.1 Company 2
Illustrative

36. 36 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Company Name Type Year Key Pointers
Latest Deals in CompanyName
Illustrative
5.2.1 Company 2 (Continued)

37. 37 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.2.1 Company 2 (Continued)

38. Thailand Dialysis Market Analysis
6. Regulatory and Reimbursement Landscape

39. 39 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Thailand Food and Drug Administration (TFDA)
▪The regulatory authority for pharmaceuticals and medical devices in Thailand is the TFDA which falls under the Ministry of Public
Health
▪It plays a crucial role in ensuring the safety and quality of pharmaceuticals and medical devices available in the country
▪Responsibilities of TFDA:
▪Registration and Evaluation: The TFDA is responsible for registering, evaluating, and monitoring the safety, quality, and efficacy of all
pharmaceuticals and medical devices before they can be imported, manufactured, or distributed in Thailand.
▪Compliance Enforcement: They enforce compliance with relevant laws and regulations related to pharmaceuticals and medical
devices.
▪Consumer Protection: The TFDA safeguards public health by ensuring the safety and effectiveness of pharmaceuticals and medical
devices available in Thailand.
▪Medical Device Control Division (MDCD)
▪MDCD manages the registration, evaluation, and monitoring of medical devices. This division is particularly relevant for the inquiry
about medical devices. Thailand's medical device regulations are based on the Medical Device Act B.E. 2551 (2008) and updated
amendments.
▪TFDA classifies medical devices into different risk categories based on their potential impact on patient safety. This classification
determines the level of regulatory scrutiny required for registration.
▪Thailand is also in the process of aligning its national legislation with the Association of Southeast Asian Nations (ASEAN) Medical
Device Directives (AMDD) for greater regional harmonization.
Illustrative
Regulatory Authorities With Jurisdiction Over Drugs, Biologicals, And Medical Devices In Thailand
6.1 Regulatory Landscape in Thailand

40. 40 A Sample Report on Thailand Dialysis Market Analysis I Confidential
▪Universal Coverage Scheme (UCS)
▪Covers approximately 75% of the population
▪Funded by payroll taxes and government contributions
▪Reimbursement rates for in-patient care are around 80% and for out-patient care, it is between 50% and 70%
▪Patients might have co-payments for some services or medications not included in the UC benefit package
▪Civil Servant Medical Benefit Scheme (CSMBS)
▪Funded by government contributions
▪Provides healthcare benefits to government employees, their dependents, and retirees
▪Offers a more comprehensive benefit package with lower co-payments compared to the UC scheme
▪Social Security Scheme (SSS)
▪Covers private sector employees and their dependent who contribute through payroll deductions
▪Offers similar benefits to the UCS but with potential variations in co-payments
Illustrative
Regulatory Framework For The Authorization, Pricing, And Reimbursement Of Drugs
6.2 Reimbursement Scenario in Thailand

41. 41 A Sample Report on Thailand Dialysis Market Analysis I Confidential
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Thailand healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.2 Reimbursement Scenario in Thailand (Continued)

42. 42 A Sample Report on Thailand Dialysis Market Analysis I Confidential
The reimbursement process in Thailand healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.3 Reimbursement Process

43. 43 A Sample Report on Thailand Dialysis Market Analysis I Confidential
The reimbursement process in Thailand healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.3 Reimbursement Process (Continued)

44. A division
of

45. Life-sciences Market Research
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.

46. At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)

47. Click on the country to see the reports
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco

48. What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10

49. 01 0302 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process

50. Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation

51. 2023
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.

52. We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases

53. Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works

54. Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services

55. “The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks

56. Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team

57. @Our Team

58. @Work

59. Beyond Work

60. … and many more
Pi-SM
GmbH
Our Clients

61. I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say

62. Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say

63. Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say

64. Thank You
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: ([phone]
We would be happy to help.
Do you have
any questions?